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Editorial
a critical view of magnetic resonance imaging 
in the evaluation of motor neuron diseases
Uma visão crítica da ressonância nuclear magnética na avaliação das doenças do neurônio motor
Cláudia da Costa Leite
Some neurodegenerative diseases, such as Alzheimer and amyotrophic lateral scle-rosis (ALS) or primary LS (PLS), do not have specific magnetic resonance imaging (MRI) findings or these findings are inconsistent, especially in their early stages. In this setting, MRI plays a role in the exclusion of other diagnosis, which could explain 
the clinical picture and give support for a clinical diagnosis of these entities. 
New MRI techniques, also known as nonconventional or functional, have been used 
especially in the research field, trying to help in the early diagnosis of these neurodegen-
erative diseases and also as tools to monitor disease evolution and response to treatment. 
Sometimes, they can give additional information disclosing an extent of brain involvement, 
which is not evident using conventional MRI sequences, giving new insights in the under-
standing of their pathophysiology. The use of new imaging modalities aim at doing their 
earlier diagnosis1,2.
As MRI is a noninvasive and reproducible imaging method, it has been extensively ap-
plied to neurologic diseases. Nonconventional MRI techniques has been used in the assess-
ment of multiple sclerosis and their use was expanded from the research field to drug tri-
als and clinical practice. Magnetization transfer contrast, diffusion tensor imaging, proton 
spectroscopy, functional MRI, and volumetric techniques have been used to detect brain 
abnormalities in normal appearing white and gray matter and to evaluate function com-
promise or brain regional atrophy in multiple sclerosis3. The extended application of these 
techniques for other neurological diseases may improve diagnosis and understanding of 
brain involvement.
ALS/PLS is a neurodegenerative disease that affects the motor system. Clinical mani-
festations are related to compromise of upper and lower motor neurons. The standard 
diagnostic criteria for ALS/PLS, proposed by Brooks et al.4, are based on clinical findings. 
The most recent Awaji criteria5 associate electromyography findings and clinical mani-
festations for ALS/PLS diagnosis; however, imaging findings are not considered in these 
criteria.
Conventional MRI findings are not considered in the criteria for the diagnosis of ALS/
PLS since they are not always present, and many times they are not specific (sometimes 
they are also identified in the normal population)1. The main role of conventional MRI 
nowadays is still to detect structural lesions that can exclude the diagnosis of ALS/PLS.
This issue of Arquivos de Neuro-Psiquiatria presents a very interesting review by Rocha 
and Maia Jr. of MRI findings in ALS/PLS that is focused on conventional and nonconven-
tional MRI techniques, such as magnetization transfer contrast (MTC), proton spectroscopy 
(MRS), diffusion tensor imaging (DTI), and voxel-based morphometry (VBM)6. This article 
shows a critical discussion of the clinical application of these techniques in ALS/PLS in the 
early diagnosis, as well as in the follow-up and in the treatment control of these patients.
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